Clinical and academic researchers can apply for one of three spots for free access to cardiac remote monitoring and ILR ECG Analyzer to support CRM research CAMBRIDGE, Mass., March 10, 2022 /PRNewswire/ — Implicity, a leader in AI-powered remote patient monitoring and cardiac data management solutions, today announced an invitation for US-based researchers […]
Other News
Lohman Technologies Releases White Paper: The Impact of Remote Cardiac Monitoring on the Care Continuum
PEWAUKEE, Wis. and MEMPHIS, Tenn. , March 10, 2022 /PRNewswire/ — Lohman Technologies, a leader in home ECG monitoring solutions, released the findings from a 90-day pilot study at a Memphis, TN clinic. The goal of the pilot was to empower patients to collect daily ECG readings and have them sent directly to their primary care provider. The […]
S.M.A.R.T. RADIANZ™ Vascular Stent System Approved for Transradial Use in the U.S.
Completes the RADIANZ Radial Peripheral System™; signals Cordis’ renewed investment in innovation MIAMI LAKES, Fla., March 10, 2022 /PRNewswire/ — Cordis, a global cardiovascular technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T. RADIANZ™ Vascular Stent System, a self-expanding stent purposefully engineered for radial peripheral procedures. […]
MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan
– MCRA’s acquisition of Vorpal Technologies K.K. (Vorpal) bolsters MCRA’s ability to support a domestic market within Asia, expanding MCRA’s overall geographical footprint allowing MCRA to be closer to its client base and their target markets. – Vorpal is the preeminent MedTech consulting firm for Japan and leader in new […]
Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO
SHANGHAI, March 10, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Ms. Jessie Lian Jia as Chief Executive Officer and Executive Director of the Board. Ms. Lian has more than 20 years of international leadership experience in product commercialization, strategic business development and capital market […]
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., March 9, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on March 4, 2022, the compensation committee of the company’s board of directors granted ten new non-executive employees options […]
Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA® significantly reduced the risk of cardiovascular death, strokes, heart attacks, coronary revascularization, and unstable angina by 34% in patients with a history of percutaneous coronary intervention (PCI).(1) Icosapent ethyl […]
Sequana Medical Announces New Share Capital Amount and New Number of Shares
GHENT, Belgium, March 10, 2022 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces that in the context of the capital increase that was announced on 7 March 2022 and completed […]
HeartBeam Partners with Triple Ring Technologies to Co-Develop Telehealth Solution Device
3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a professional services agreement (the “Agreement”) with […]
Imbria Pharmaceuticals Strengthens Executive Leadership Team with New Appointments
Dr. Arash Yavari Appointed to Chief Scientific Officer Hugo Fry Appointed to Chief Commercial Officer Komal Joshi Appointed to Chief Financial Officer BOSTON–(BUSINESS WIRE)–Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, today announced the appointments of Arash Yavari, M.B.B.S., DPhil., M.R.C.P., as […]



